Severity
Moderate
FDA Drug recall · Reported October 23, 2019
Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a corn source.
Atlas Pharmaceuticals, LLC recalled Ascorbic Acid Sterile Injection Solution, 500 mg/mL, 50 mL vial, Non-Corn Source, Rx only… - a moderate-severity action.
Ascorbic Acid Sterile Injection Solution, 500 mg/mL, 50 mL vial, Non-Corn Source, Rx only… was recalled by Atlas Pharmaceuticals, LLC in October 23, 2019. Reason: Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a cor…. Check the official notice for the remedy. Verify recall #D-0144-2020 with the FDA Drug before acting.
The recall
Atlas Pharmaceuticals, LLC issued this moderate-severity FDA Drug recall-Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a cor….
Sourced from official FDA Drug enforcement records. Verify recall #D-0144-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0144-2020) was formally reported on October 23, 2019, with the manufacturer initiating the action on August 28, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. Atlas Pharmaceuticals, LLC is listed as the recalling firm, operating out of Phoenix, AZ. Federal records list the affected scope as 1646 vials.
The documented reason for this recall is: Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a corn source. Distribution data in the federal record shows the product reached: Healthcare facilities/clinics in AZ and CO. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1646 vials
Related Recalls
6
5 from same agency
Ascorbic Acid Sterile Injection Solution, 500 mg/mL, 50 mL vial, Non-Corn Source, Rx only, Atlas Pharmaceuticals, LLC, 711 E Carefree Hwy, Suite 107, Phoenix, AZ 85085, NDC 71591-500-50.
Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a corn source.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0144-2020 |
| Date reported | October 23, 2019 |
| Date initiated | August 28, 2019 |
| Recalling firm | Atlas Pharmaceuticals, LLC |
| Firm location | Phoenix, AZ |
| Affected scope | 1646 vials |
| Distribution | Healthcare facilities/clinics in AZ and CO |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported October 23, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.